Sofosbuvir Recruiting Phase 2 Trials for Hepatitis C Viral Infection / Hepatitis C, Acute Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03818308Trial for the Treatment of Acute Hepatitis C for 8 Weeks With Sofosbuvir/Velpatasvir